Nyrada (ASX:NYR) Total Equity: A$9.84 Mil (As of Dec. 2025)


ASX:NYR Nyrada Inc ASX:NYR
38 GF Score
Price A$0.44
! 1 Warning Sign
View Full Analysis

What is Nyrada Total Equity?

Nyrada ASX:NYR 38 Total Equity is A$9.84 Mil as of Dec. 2025. GuruFocus rates ASX:NYR with a GF Score™ of 38/100. The stock has 1 warning sign investors should review.

Nyrada's total equity for the quarter that ended in Dec. 2025 was A$9.84 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Nyrada Total Equity Historical Data

* Premium members only.

The historical data trend for Nyrada's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nyrada Total Equity Chart

Nyrada Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Equity
Get a 7-Day Free Trial 14.49 11.50 4.26 5.05 3.58

Nyrada Semi-Annual Data
Jun19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.58 5.05 5.86 3.58 9.84
ASX:NYR
38GF Score
Nyrada Inc ASX:NYR
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nyrada Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Nyrada's Total Equity for the fiscal year that ended in Jun. 2025 is calculated as

Total Equity=Total Assets(Q: Jun. 2025 )-Total Liabilities(Q: Jun. 2025 )
=5.3-1.723
=3.58

Nyrada's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=10.393-0.549
=9.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of A$9.84 Mil mean?
Nyrada (ASX:NYR) has a Total Equity of A$9.84 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Nyrada and its competitors.
Is Nyrada's Total Equity too high?
Nyrada's current Total Equity is A$9.84 Mil. Overall, Nyrada has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Nyrada's Total Equity compare to VRTX and REGN?
Nyrada's Total Equity of A$9.84 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Nyrada and its competitors. Nyrada's current Total Equity is A$9.84 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nyrada stock overvalued right now?
Nyrada (ASX:NYR) has a current Total Equity of A$9.84 Mil. The current Total Equity is A$9.84 Mil. Nyrada's overall GF Score™ is 38/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Nyrada (ASX:NYR), the current Total Equity is A$9.84 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nyrada Business Description

Address 180 George Street, Sydney Place, Level 22/23, Salesforce Tower, Sydney, NSW, AUS, 2000
Nyrada Inc is a preclinical-stage, drug discovery, and development company, specializing in novel small-molecule drugs to treat cardiovascular and neurological diseases. It operates in one segment: research and development of drugs focusing on small molecules with potential therapeutic benefit in areas of medical needs. The company's two programs center on cholesterol-lowering and brain injury, each targeting market sectors of notable size and unmet clinical needs. The programs are focused on developing an oral, small molecule cholesterol-lowering drug, and a drug to treat secondary brain damage following a stroke or traumatic brain injury.
38GF Score

Get the complete analysis for ASX:NYR

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.44
Price